471,000 Mislabeled Insulin Syringes Recalled

Law360, New York (November 6, 2008, 12:00 AM EST) -- A Massachusetts-based health care firm and the U.S. Food and Drug Administration issued a nationwide recall on Thursday for nearly half a million disposable hypodermic insulin syringes due to a mislabeling error that could give patients as much as 2.5 times the intended dose.

Covidien, formerly Tyco Healthcare Group, of Mansfield, Mass. manufactures the ReliOn single-use disposable Insulin syringes and issued a voluntary recall of the product earlier this month, asking its distributors to take the product of the shelves.

The company claims that during the...
To view the full article, register now.